• 1
    Cregg JM, Tolstorukov I, Kusari A, Sunga J, Madden K, Chappell T (2009) Expression in the yeast Pichia pastoris. Methods Enzymol 463:169189.
  • 2
    Damasceno LM, Huang CJ, Batt CA (2012) Protein secretion in Pichia pastoris and advances in protein production. Appl Microbiol Biotechnol 93:3139.
  • 3
    Jahic M, Veide A, Charoenrat T, Teeri T, Enfors SO (2006) Process technology for production and recovery of heterologous proteins with Pichia pastoris. Biotechnol Prog 22:14651473.
  • 4
    Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM (2005) Heterologous protein production using the Pichia pastoris expression system. Yeast 22:249270.
  • 5
    Jeong KJ, Jang SH, Velmurugan N (2011) Recombinant antibodies: engineering and production in yeast and bacterial hosts. Biotechnol J 6:1627.
  • 6
    Wildt S, Gerngross TU (2005) The humanization of N-glycosylation pathways in yeast. Nature Rev Microbiol 3:119128.
  • 7
    Jarvis DL (2009) Baculovirus-insect cell expression systems. Methods Enzymol 463:191222.
  • 8
    Unger T, Peleg Y (2012) Recombinant protein expression in the baculovirus-infected insect cell system. Methods Mol Biol 800:187199.
  • 9
    Rendic D, Wilson IBH, Paschinger K (2008) The glycosylation capcity of insect cells. Croatica Chem Acta 81:721.
  • 10
    Frenzel A, Hust M, Schirrmann T (2013) Expression of recombinant antibodies. Front Immunol 4:217.
  • 11
    .Hasemann CA, Capra JD (1990) High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system. Proc Natl Acad Sci USA 87:39423946.
  • 12
    Ailor E, Betenbaugh MJ (1998) Overexpression of a cytosolic chaperone to improve solubility and secretion of a recombinant IgG protein in insect cells. Biotechnol Bioengin 58:196203.
  • 13
    Ailor E, Betenbaugh MJ (1999) Modifying secretion and post-translational processing in insect cells. Curr Opin Biotechnol 10:142145.
  • 14
    Hsu TA, Betenbaugh MJ (1997) Coexpression of molecular chaperone BiP improves immunoglobulin solubility and IgG secretion from Trichoplusia ni insect cells. Biotechnol Prog 13:96104.
  • 15
    Hsu TA, Watson S, Eiden JJ, Betenbaugh MJ (1996) Rescue of immunoglobulins from insolubility is facilitated by PDI in the baculovirus expression system. Protein Express Purif 7:281288.
  • 16
    Butler M (2005) Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol 68:283291.
  • 17
    Chusainow J, Yang YS, Yeo JH, Toh PC, Asvadi P, Wong NS, Yap MG (2009) A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer? Biotechnol Bioengin 102:11821196.
  • 18
    Jenkins N, Meleady P, Tyther R, Murphy L (2009) Strategies for analysing and improving the expression and quality of recombinant proteins made in mammalian cells. Biotechnol Appl Biochem 53:7383.
  • 19
    Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Advan 30:11581170.
  • 20
    Fike R (2010) Nutrient supplementation strategies for biopharmeceutical production, Part 3: Scaling strategies for rapid nutrient supplement prototyping. Bioprocess Internatl 8:2431.
  • 21
    Ye J, Kober V, Tellers M, Naji Z, Salmon P, Markusen JF (2009) High-level protein expression in scalable CHO transient transfection. Biotechnol Bioengin 103:542551.
  • 22
    Durocher Y, Perret S, Kamen A (2002) High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30:E9.
  • 23
    Pham PL, Perret S, Doan HC, Cass B, St-Laurent G, Kamen A, Durocher Y (2003) Large-scale transient transfection of serum-free suspension-growing HEK293 EBNA1 cells: peptone additives improve cell growth and transfection efficiency. Biotechnol Bioengin 84:332342.
  • 24
    Chaudhary S, Pak JE, Pedersen BP, Bang LJ, Zhang LB, Ngaw SM, Green RG, Sharma V, Stroud RM (2011) Efficient expression screening of human membrane proteins in transiently transfected Human Embryonic Kidney 293S cells. Methods 55:273280.
  • 25
    Lufino MM, Edser PA, Wade-Martins R (2008) Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression. Molecular Therapy 16:15251538.
  • 26
    Van Craenenbroeck K, Vanhoenacker P, Haegeman G (2000) Episomal vectors for gene expression in mammalian cells. Eur J Biochem/ FEBS 267:56655678.
  • 27
    Barnes LM, Bentley CM, Dickson AJ (2000) Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology 32:109123.
  • 28
    Cacciatore JJ, Chasin LA, Leonard EF (2010) Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system. Biotechnology Advan 28:673681.
  • 29
    Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM (2008) Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 36:e96.
  • 30
    Kozak M (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:81258148.
  • 31
    Kozak M (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196:947950.
  • 32
    Kozak M (2002) Emerging links between initiation of translation and human diseases. Mammalian Genome 13:401410.
  • 33
    Zufferey R, Donello JE, Trono D, Hope TJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virology 73:28862892.
  • 34
    Schambach A, Bohne J, Baum C, Hermann FG, Egerer L, von Laer D, Giroglou T (2006) Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Therapy 13:641645.
  • 35
    Popa I, Harris ME, Donello JE, Hope TJ (2002) CRM1-dependent function of a cis-acting RNA export element. Mol Cell Biol 22:20572067.
  • 36
    Buchman AR, Berg P (1988) Comparison of intron-dependent and intron-independent gene expression. Mol Cell Biol 8:43954405.
  • 37
    Le Hir H, Nott A, Moore MJ (2003) How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci 28:215220.
  • 38
    Stern B, Olsen LC, Trobe C, Ravneberg H, Pryme IF (2007) Improving mammalian cell factories: the selection of signal peptide has a major impact on recombinant protein synthesis and secretion in mammalian cells. Trends Cell Mol Biol 2:117.
  • 39
    Kober L, Zehe C, Bode J (2013) Optimized signal peptides for the development of high expressing CHO cell lines. Biotechnol Bioengin 110:11641173.
  • 40
    Carter J, Zhang J, Dang TL, Hasegawa H, Cheng JD, Gianan I, O'Neill JW, Wolfson M, Siu S, Qu S, Meininger D, Kim H, Delaney J, Mehlin C (2010) Fusion partners can increase the expression of recombinant interleukins via transient transfection in 2936E cells. Protein Sci 19:357362.
  • 41
    Zhang J, Carter J, Siu S, O'Neill JW, Gates AH, Delaney J, Mehlin C (2010) Fusion partners as a tool for the expression of difficult proteins in mammalian cells. Curr Pharm Biotechnol 11:241245.
  • 42
    Becker B, Cooper MA (2013) Aminoglycoside antibiotics in the 21st century. ACS Chem Biol 8:105115.
  • 43
    Lacalle RA, Pulido D, Vara J, Zalacain M, Jimenez A (1989) Molecular analysis of the pac gene encoding a puromycin N-acetyl transferase from Streptomyces alboniger. Gene 79:375380.
  • 44
    Mancia F, Patel SD, Rajala MW, Scherer PE, Nemes A, Schieren I, Hendrickson WA, Shapiro L (2004) Optimization of protein production in mammalian cells with a coexpressed fluorescent marker. Structure 12:13551360.
  • 45
    Bouabe H, Fassler R, Heesemann J (2008) Improvement of reporter activity by IRES-mediated polycistronic reporter system. Nucleic Acids Res 36:e28.
  • 46
    Vogel C, Marcotte EM (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nature Rev Genetics 13:227232.
  • 47
    Gasser CS, Simonsen CC, Schilling JW, Schimke RT (1982) Expression of abbreviated mouse dihydrofolate reductase genes in cultured hamster cells. Proc Natl Acad Sci USA 79:65226526.
  • 48
    Wurm FM (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnol 22:13931398.
  • 49
    DuBridge RB, Calos MP (1988) Recombinant shuttle vectors for the study of mutation in mammalian cells. Mutagenesis 3:19.
  • 50
    Backliwal G, Hildinger M, Hasija V, Wurm FM (2008) High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI. Biotechnol Bioengin 99:721727.
  • 51
    Tom R, Bisson L, Durocher Y (2008) Transfection of HEK293-EBNA1 cells in suspension with linear PEI for production of recombinant proteins. CSH Protocols 2008:pdb prot4977.
  • 52
    Geisse S, Fux C (2009) Recombinant protein production by transient gene transfer into Mammalian cells. Methods Enzymol 463:223238.
  • 53
    Brunner D, Frank J, Appl H, Schoffl H, Pfaller W, Gstraunthaler G (2010) Serum-free cell culture: the serum-free media interactive online database. Altex 27:5362.
  • 54
    Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci USA 99:1341913424.
  • 55
    Hatton T, Barnett S, Benninghoff AD, Rashid K (2012) Productivity studies utilizing recombinant CHO cells in stirred-tank bioreactors: a comparitive study between pitched-blad and packed-bed bioreactor systems. BioProcessing J 11:2936.
  • 56
    Meuwly F, Ruffieux PA, Kadouri A, von Stockar U (2007) Packed-bed bioreactors for mammalian cell culture: bioprocess and biomedical applications. Biotechnology Advan 25:4556.
  • 57
    Racher AJ, Fooks AR, Griffiths JB (1995) Culture of 293 cells in different culture systems: Cell growth and recombinant adenovirus production. Biotechnol Tech 9:169174.
  • 58
    Graham FL (1987) Growth of 293 cells in suspension culture. J Gen Virology 68:937940.
  • 59
    Cervera L, Gutierrez S, Godia F, Segura MM (2011) Optimization of HEK 293 cell growth by addition of non-animal derived components using design of experiments. BMC Proc 5 Suppl 8:P126.
  • 60
    van der Valk J, Brunner D, De Smet K, Fex Svenningsen A, Honegger P, Knudsen LE, Lindl T, Noraberg J, Price A, Scarino ML, Gstraunthaler G (2010) Optimization of chemically defined cell culture media—replacing fetal bovine serum in mammalian in vitro methods. Toxicology in vitro 24:10531063.
  • 61
    Allen MJ, Boyce JP, Trentalange MT, Treiber DL, Rasmussen B, Tillotson B, Davis R, Reddy P (2008) Identification of novel small molecule enhancers of protein production by cultured mammalian cells. Biotechnol Bioengin 100:11931204.
  • 62
    Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM (2008) Valproic acid: a viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioengin 101:182189.
  • 63
    Fike R (2009) Nutrient supplementation strategies for biopharmeceutical production, Part 1: Identifying a formulation. Bioprocess Internatl 7:4451.
  • 64
    Barton WA, Tzvetkova-Robev D, Erdjument-Bromage H, Tempst P, Nikolov DB (2006) Highly efficient selenomethionine labeling of recombinant proteins produced in mammalian cells. Protein Sci 15:20082013.